Remimazolam was associated with a reduced need for inotropes and vasopressors after cardiopulmonary bypass compared to sevoflurane, but did not improve overall clinical outcomes.
Does remimazolam reduce the requirement of inotropes and vasopressors compared to sevoflurane in patients undergoing cardiopulmonary bypass surgery?
In patients undergoing cardiopulmonary bypass, remimazolam reduces the need for postoperative inotropes and vasopressors compared to sevoflurane, without improving overall clinical outcomes.
Absolute Event Rate: 0% vs 0%
Remimazolam use was associated with a reduced need for inotrope and vasopressor after cardiopulmonary bypass. However, no improvements in clinical outcomes were observed. Prospective studies are required to verify whether remimazolam is preferable to conventional anesthetics during cardiac surgery.
Takahashi et al. (Sun,) reported a other. Remimazolam was associated with a reduced need for inotropes and vasopressors after cardiopulmonary bypass compared to sevoflurane, but did not improve overall clinical outcomes.